Literature DB >> 11594936

Pseudotumor cerebri.

S Bandyopadhyay1.   

Abstract

Probable cases of pseudotumor cerebri were described more than a hundred years ago. A great deal of controversy existed regarding proper terminology and disease characterization. The clinical entity was doubtful before the routine use of ventriculography in the 1930s. Throughout history, many terms have been used, including serous meningitis, pseudotumor cerebri, otitic hydrocephalus, angioneurotic hydrocephalus, toxic hydrocephalus, meningeal hypertension, hypertensive meningeal hydrops, pseudoabscess, intracranial hypertension of unknown cause, papilledema of indeterminate etiology, intracranial pressure without brain tumor, benign intracranial hypertension, and idiopathic intracranial hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594936     DOI: 10.1001/archneur.58.10.1699

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Polyclonal B-cell expansion in the cerebrospinal fluid of patients with pseudotumor cerebri.

Authors:  Reng-Rong Da; Grace Kao; Wen-Zhong Guo; Michael Olek; Sudhir Gupta; Yiping Zhang; Stanley Van Den Noort; Yufen Qin
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

2.  Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension.

Authors:  Sudhakar R Satti; Lakshmi Leishangthem; Alejandro Spiotta; M Imran Chaudry
Journal:  Interv Neuroradiol       Date:  2017-01-10       Impact factor: 1.610

3.  Clinical profile, evaluation, management and visual outcome of idiopathic intracranial hypertension in a neuro-ophthalmology clinic of a tertiary referral ophthalmic center in India.

Authors:  S Ambika; Deepak Arjundas; Veena Noronha
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

4.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.